Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Testing and health monitoring news

Show

From To
SEARCH study exceeds 90-90-90 targets after 2 years of 'test and treat' for HIV in rural East Africa

A large study that embeds 'test and treat' for HIV within a larger multi-disease prevention campaign in rural Kenya and Uganda has achieved 82% viral suppression after

Published
20 July 2016
By
Keith Alcorn
Progress towards 90-90-90 targets in southern Africa: find the men!

Studies of treatment cascade performance in South Africa and Namibia show large variations between districts and highlight the need for up-to-date information on performance to guide programming,

Published
20 July 2016
By
Keith Alcorn
More confidence on zero risk: still no transmissions seen from people with an undetectable viral load in PARTNER study

The PARTNER study, which two years ago created headlines by establishing that the chance of an HIV-positive person with an undetectable viral load transmitting their virus was

Published
19 July 2016
By
Gus Cairns
Progress towards 90-90-90 targets is promising, but funding is the critical step, says UNAIDS leader

The 90-90-90 targets for testing, treatment and viral suppression are achievable by 2020 in many high-burden countries, but donor retreat is now the biggest threat to widespread

Published
18 July 2016
By
Keith Alcorn
Alere HIV Combo Test Receives WHO Prequalification

Alere, a global leader in rapid diagnostics, today announced that its Alere HIV Combo, a rapid point-of-care fourth-generation test that detects both HIV-1/2 antibodies and the HIV-1 p24 antigen, has been awarded World Health Organization (WHO) prequalification, making it available for public sector procurement in resource-limited countries.

Published
17 July 2016
From
Alere press release
AVAC Report 2016: Big Data Real People

This year’s AVAC Report takes on one of the most urgent issues facing biomedical HIV prevention today: gaps in the type and quality of data collected on prevention for HIV-negative people. Globally, the number of new HIV infections is not declining. In the places where gains have been made, continued progress is not guaranteed. Fixing core problems with how prevention data are collected and reported is key to slowing the rate of new cases of HIV.

Published
15 July 2016
From
AVAC
Almost 5 million workers reached under ILO’s VCT@WORK initiative and 3 million tested for HIV

The International Labour Organization (ILO) has announced that the initial phase of its VCT@WORK initiative has reached close to 5 million workers with face-to-face education on the benefits of HIV testing. During the outreach, which took place between July 2013 and December 2015, almost 3 million workers were tested for HIV, and more than 85 000 people who tested positive for HIV were referred to services for treatment.

Published
15 July 2016
From
UNAIDS
Prince Harry takes HIV test live on camera

Royal was filmed getting checkup at Guy’s and St Thomas’s hospital to encourage others and remove stigma of tests.

Published
14 July 2016
From
The Guardian
Challenges Loom for Point-of-Care Diagnostics

POC is likely to grow in emerging markets, where limited resources and local conditions make traditional lab-based testing less practical.

Published
13 July 2016
From
Genetic Engineering & Biotechnology News
MSF Report - Making Viral Load Routine

Based on a survey performed across ten MSF supported ART sites and seven viral load testing laboratories in February 2016, “Making viral load routine” aims to share practical lessons from the field with Ministries of Health and implementing partners. The report reflects both on the programmatic strategies required within the clinic (for clinicians, counsellors and patients) and the realities of both setting up and keeping a viral load testing laboratory functional in such settings.

Published
12 July 2016
From
MSF

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.